Tulathromycin for Sheep: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Tulathromycin is a prescription macrolide antibiotic in the triamilide family. It works by interfering with bacterial protein synthesis, which helps stop susceptible bacteria from growing. In food animals, it is best known under brand names such as Draxxin and Tulissin 100.

In the United States, tulathromycin is FDA-approved for certain cattle and swine uses, but not specifically for sheep. That means use in sheep is generally extra-label and must be directed by your vet within a valid veterinary-client-patient relationship. For sheep, this matters because your vet also has to set an appropriate meat withdrawal time and determine whether the drug is suitable for the flock, the diagnosis, and the production goals.

Tulathromycin is popular in large-animal practice because it tends to stay in the body for a relatively long time and concentrates well in lung tissue. That can make it a practical option when handling stress needs to be minimized and a single injection may be preferable to repeated dosing. Even so, it is not the right antibiotic for every case, and culture, flock history, and local resistance patterns still matter.

In sheep, tulathromycin is most often considered for bacterial respiratory disease, especially when your vet suspects organisms that may respond to a macrolide antibiotic. Merck notes that macrolides are among the antimicrobial classes used for respiratory disease in sheep and goats, and tulathromycin has activity against important respiratory pathogens in other livestock species.

Your vet may also consider tulathromycin in some cases of foot rot or other soft-tissue bacterial infections when the likely bacteria and flock circumstances support that choice. Outside the US, tulathromycin products are labeled in some sheep markets for treatment of foot rot associated with Dichelobacter nodosus, which supports why vets may discuss it as an option in sheep even though US use is extra-label.

This medication is not useful for viral disease, parasites, or noninfectious causes of coughing, lameness, or fever. A sheep with pneumonia-like signs could have bacterial pneumonia, lungworms, aspiration, severe stress, or another problem entirely. That is why your vet may recommend an exam, temperature check, lung auscultation, and sometimes culture or necropsy information before choosing tulathromycin.

Tulathromycin dosing in sheep should come only from your vet. Published pharmacokinetic work in adult ewes found that a single 2.5 mg/kg injection produced drug exposure similar enough to cattle and goats to support similar dosing assumptions in sheep, and this is the dose most commonly referenced in sheep literature. Because most injectable products contain 100 mg/mL, that works out to 1 mL per 40 kg body weight.

The exact route matters. In published sheep studies, tulathromycin has been evaluated at 2.5 mg/kg given subcutaneously and also 2.5 mg/kg given intramuscularly in some non-US product information. Your vet will choose the route, injection site, and maximum volume per site based on the product being used, the sheep's size, and residue considerations.

Do not guess the dose from cattle, goat, or online farm-forum advice. Sheep that are underdosed may not respond well and may contribute to antimicrobial resistance. Sheep that are overdosed may have more injection-site pain or other adverse effects. Because sheep are food animals, your vet also needs to provide a meat withdrawal interval, and tulathromycin should generally be avoided in animals producing milk for human consumption unless your vet specifically addresses residue risk and legality.

Tulathromycin is usually well tolerated in livestock, but the most common problem is a temporary injection-site reaction. Sheep may show brief discomfort such as head shaking, rubbing at the injection site, or stepping away during or shortly after the injection. Mild local swelling or tissue irritation can also occur.

As with many injectable antibiotics, there is also a small risk of allergic or anaphylactoid reactions. These are uncommon, but they are urgent. Call your vet right away if a sheep develops facial swelling, collapse, severe weakness, trouble breathing, or sudden widespread distress after treatment.

You should also contact your vet if the sheep stops eating, becomes more depressed, develops worsening fever, or fails to improve within the timeframe your vet discussed. Sometimes that means the infection is more severe than expected, the bacteria are not susceptible, or the original diagnosis needs to be reconsidered.

Tulathromycin should not be combined casually with other antibiotics or medications without veterinary guidance. In general, your vet will avoid unnecessary antibiotic combinations and will choose drugs based on the likely bacteria, tissue penetration, and withdrawal planning.

As a macrolide, tulathromycin may have overlapping activity with other macrolides, so using multiple drugs from the same family is usually not helpful. Merck also notes that coadministration of rifampin/rifampicin with tulathromycin has reduced tulathromycin concentrations in the lungs in foals, which is a useful reminder that drug combinations can change how this antibiotic behaves in the body.

Practical interaction concerns in sheep often involve the whole treatment plan, not only one direct drug-drug conflict. Anti-inflammatories, fluids, dewormers, and other antibiotics may all be appropriate in some cases, but they should be selected by your vet so the plan fits the diagnosis, the animal's age and pregnancy status, and food-animal residue rules.